Acenocoumarol or warfarin: Which is the clinician’s ally?

N. Karthik Rao, Navin Patil, A. Avinash, Handattu Manjunatha Hande, Sushil Kiran Kunder, N. Raghavendra Rao

Research output: Contribution to journalArticlepeer-review


Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.

Original languageEnglish
Pages (from-to)4-5
Number of pages2
JournalAsian Journal of Pharmaceutical and Clinical Research
Issue number2
Publication statusPublished - 01-03-2016

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)


Dive into the research topics of 'Acenocoumarol or warfarin: Which is the clinician’s ally?'. Together they form a unique fingerprint.

Cite this